▌Top Stocks · MONTHLY DIVIDENDS·Updated September 16, 2026
Best Monthly Dividend Stocks for September 2026: 7 Picks
This countdown spans healthcare and industrial REITs, mortgage finance, and private-credit BDCs, giving income investors seven monthly-dividend candidates to compare.
Top Stocks · MONTHLY DIVIDENDSUpdated September 16, 2026
Monthly dividends remain a durable income niche as investors look for frequent cash flow, smoother compounding and an equity portfolio that can feel somewhat more bond-like without abandoning upside potential. The appeal is especially relevant in a higher-rate environment, but the backdrop also demands more selectivity. Financing costs, refinancing risk, payout coverage, tax treatment and total return can matter more than the calendar frequency of a distribution. For income investors, a monthly schedule is useful only when supported by a durable business model and recurring cash flow.
The opportunity set spans traditional net-lease and diversified REITs, mortgage REITs, business development companies, preferred-stock vehicles, closed-end funds and newer options-based ETFs. Each carries a different risk profile: REITs depend on property income and financing conditions, BDCs provide private-credit exposure, and mortgage vehicles are particularly sensitive to rates, leverage and spread movements. The market is also still experimenting with payout cadence; Strategy's June 2026 shareholder approval to move STRC from monthly to semi-monthly record and payment dates illustrates that frequency remains an area of innovation.
This countdown brings together seven U.S.-listed companies with meaningful exposure to the monthly-dividend ecosystem. The list moves from #7 to #1, combining healthcare and industrial real estate with mortgage finance and private credit. The ranking emphasizes how directly each business fits the theme first, then weighs profitability, growth, valuation, earnings execution and analyst sentiment. The result is not a yield-only screen; it is a comparison of the business engines behind frequent income strategies.
Methodology brief: We screened U.S.-listed companies with market capitalizations above $500 million and a direct or structural connection to monthly-income investing. Positions were ordered primarily by depth of exposure to the theme, followed by business fundamentals, including profitability, revenue and earnings trends, valuation, recent earnings performance and analyst consensus. Composite quality grades provide an additional reference point but do not override the thematic ranking. The article is presented in countdown order, so the best pick is revealed at #1 rather than at the beginning.
What they do. The company is a healthcare REIT focused on seniors housing and healthcare properties. It invests through operating partnerships, triple-net leases, joint ventures and structured finance solutions, with a portfolio of nearly 190 properties across the United States. About 70% of gross real estate investments are in seniors housing, while the remainder is in skilled nursing centers, giving LTC a concentrated exposure to healthcare real estate rather than a broad commercial-property mix.
Why it fits.LTC fits the monthly-dividend theme through recurring rent, operating-property income and structured financing tied to essential healthcare facilities. Its seniors-housing and skilled-nursing focus gives income investors a more defensive-use-case angle than many general commercial REITs, although the healthcare-operator exposure means property cash flow still depends on tenant and operator economics. The theme exposure is credible, but more specialized than a broad, dedicated monthly-dividend platform.
Numbers that matter.LTC reported a 60.5% gross margin, a 52.87% operating margin and a 39.85% net margin, alongside 11.81% return on equity and 2.76% return on assets. The fundamental trend is weaker: revenue fell 19% year over year, earnings declined 54.4%, and next-year EPS is estimated at 1.575 versus trailing EPS of 2.8. Valuation is comparatively moderate for a REIT, with trailing P/E of 15.2286 and forward P/E of 12.4533, while the composite model assigns a Strong Buy to DCF and ROA but a Neutral debt-to-equity view.
Recent momentum. The latest reported quarter produced EPS of $0.68 versus an estimate of $0.72, a 5.6% miss; the prior quarter beat by 4.5% with EPS of $0.46 versus $0.44. LTC has beaten estimates in 2 of the last 7 reported quarters. Analyst sentiment is cautious at 3.25, with 1 Buy, 5 Holds and 1 Sell, and the average target is $45, leaving the case dependent on stabilizing healthcare-property earnings rather than recent execution.
What they do. The company is a mortgage REIT that provides private capital to the U.S. housing market. It invests in residential mortgage pass-through securities and collateralized mortgage obligations whose principal and interest are guaranteed by government-sponsored enterprises or government agencies. That structure gives AGNC a highly focused mortgage-finance model rather than the property ownership and leasing model used by equity REITs.
Why it fits.AGNC is a direct route into the income theme through mortgage securities and the REIT distribution structure. Its government-backed collateral can reduce credit-loss exposure relative to unsecured lending, but the business remains highly sensitive to interest rates, funding costs, leverage and changes in the value of mortgage assets. That makes AGNC a higher-financial-sensitivity choice than a conventional property REIT, even though it belongs to the same broad income ecosystem.
Numbers that matter.AGNC posted a 94.38% net margin, a 95.61% operating margin, 19.8% return on equity and 2.03% return on assets. Revenue grew 546.1% year over year and earnings grew 772.4%, although next-year EPS is estimated at 1.5012 compared with trailing EPS of 2.01. The trailing P/E is 5.0199 and the forward P/E is 6.7659, but the composite metrics flag debt-to-equity as Strong Sell and price-to-book as Sell, highlighting the leverage and asset-value risks behind the low earnings multiple.
Recent momentum.AGNC's latest reported quarter was a 5.3% beat, with EPS of $0.40 versus an estimate of $0.38. The preceding quarter was much weaker, producing EPS of negative $0.17 against an estimate of $0.12, a 241.7% shortfall, and the company has beaten in 3 of the last 7 reported quarters. Analysts show a 3.5 consensus, with 3 Buys and 9 Holds; no Sell count was reported, and the average target is $11.0556.
What they do. The company is a business development company specializing in term loans, equipment financing and private-equity-related investments. Its lending platform covers technology, equipment, life sciences, warehouse lending and sponsor finance, while the portfolio reaches growth-stage companies across industries including software, aerospace, clean technology, semiconductors and robotics. That mix gives Trinity multiple private-credit channels rather than dependence on a single industry or financing product.
Why it fits. BDCs are one of the clearest structural components of the monthly-income universe, and TRIN offers access to private credit through loans and equipment financing. Its focus on growth-stage borrowers can support attractive interest income, while the industry-agnostic approach broadens exposure across technology, life sciences and other specialized markets. The trade-off is that credit quality, portfolio marks and funding costs are central to the durability of distributions.
Numbers that matter. Trinity reported a 100.0% gross margin, a 79.07% operating margin and a 45.15% net margin. Return on assets was 6.11% and return on equity was 12.91%, while revenue grew 19.3% year over year. Earnings declined 22%, but next-year EPS is estimated at 2.1067 compared with trailing EPS of 1.74; trailing P/E is 10.2011 and forward P/E is 8.4962. The composite grade is supported by Strong Buy profitability metrics, although debt-to-equity and price-to-book are both flagged negatively.
Recent momentum. The most recent quarter was slightly below expectations, with EPS of $0.51 versus an estimate of $0.52, a 1.9% miss. The prior quarter beat by 3.9%, and TRIN has beaten in 4 of the last 7 reported quarters. The analyst consensus is 4.25, based on 1 Hold with no Buy or Sell counts reported, while the average target is $18.5. That combination points to constructive but limited analyst coverage rather than a broad consensus.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
What they do. The company is a BDC investing in lower-middle-market businesses through senior term loans, revolving loans, first- and second-lien debt, unitranche loans, subordinated debt, mezzanine loans and equity instruments. It generally targets companies with $20 million to $150 million in sales and EBITDA between $3 million and $25 million, while individual debt investments typically range from $8 million to $40 million. The portfolio spans business services, manufacturing, healthcare, logistics, energy and other industries.
Why it fits.GLAD has deep exposure to the monthly-income theme because its core revenue engine is private lending, supplemented by equity investments. The focus on senior secured, first-lien, second-lien and unitranche structures gives income investors several layers of credit exposure, while the lower-middle-market niche can generate higher contractual income than traditional public-market debt. However, that potential comes with borrower concentration, credit-cycle and valuation risks.
Numbers that matter. Gladstone produced a 100.0% gross margin, a 74.34% operating margin and a 48.67% net margin. Revenue grew 13.1% year over year and earnings increased 68.8%, while return on equity was 9.45% and return on assets was 5.17%. Next-year EPS is estimated at 1.97 versus trailing EPS of 2.13. The trailing P/E is 9.1408 and forward P/E is 10.8225; the composite metrics rate ROA as Strong Buy and price-to-book as Buy, but DCF and debt-to-equity are weaker.
Recent momentum.GLAD's latest reported quarter came in exactly in line, with EPS of $0.49 against an estimate of $0.49. The previous two quarters were beats of 8.3% and 4.2%, and the company has beaten estimates in 3 of the last 8 reported quarters. Analysts show a 3.3333 consensus with 5 Holds and no Buy or Sell counts reported; the average target is $22. The steady recent EPS pattern supports the income case, but the mixed beat record argues for monitoring credit performance.
What they do. The company is a BDC and small business investment company providing private debt and equity capital to lower-middle-market companies, along with debt financing for middle-market acquisitions, recapitalizations, growth financing and refinancing. Its investment toolkit includes senior secured term debt, unitranche debt, subordinated debt, preferred equity and common equity. MAIN works across industries ranging from industrial services and healthcare to software, consumer services, logistics and energy.
Why it fits. Main Street is a core private-credit name for the monthly-dividend theme because it combines recurring interest income with equity participation in smaller businesses. Its ability to provide one-stop financing, including senior debt, subordinated debt and equity capital, gives the company several ways to structure investments and capture returns. That breadth can support income diversification, though BDC results remain exposed to borrower health, portfolio valuations and the cost of leverage.
Numbers that matter.MAIN reported a 100.0% gross margin, an 87.21% operating margin and a 78.49% net margin. Return on equity was 14.92% and return on assets was 5.57%; revenue grew 3.9% year over year and earnings grew 15.3%. Trailing EPS is 4.98, while next-year EPS is estimated at 3.8829. Valuation is less forgiving than at several other BDCs, with trailing P/E of 11.3193 and forward P/E of 15.456, and the composite metrics rate DCF, debt-to-equity and price-to-book negatively despite strong ROA.
Recent momentum. The latest quarter was a 2.1% EPS beat, with actual EPS of $0.97 versus an estimate of $0.95. That followed a 7.9% miss in the prior quarter, and MAIN has beaten in 2 of the last 7 reported quarters. Analyst consensus is 3.2857, with 2 Buys and 5 Holds; no Sell count was reported, and the average target is $59.5. The data suggest solid operating profitability but a valuation and execution profile that deserves more scrutiny than the business model alone.
Pick #2Premium members only
Premium members see this pick's full breakdown — investment thesis, key financial metrics, recent earnings execution, and analyst consensus.
Premium members get the complete breakdown — pick rationale, financial metrics, and recent earnings detail.
This screen covers U.S.-listed companies with market capitalizations above $500 million and a direct or structural connection to monthly-income investing. The ranking first considers depth of exposure to the theme, including whether monthly distributions are central to the business model or whether the company provides a supporting REIT, mortgage or private-credit exposure. Business fundamentals then provide the secondary ordering factor: profitability, revenue and earnings growth, valuation, earnings surprises, analyst consensus and the composite quality grade. The list is refreshed monthly so changing market data, estimates and earnings performance can influence future rankings.
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.
